Besides, the relevance of our study was confirmed in the samples of pancreatic cancer patients, and we demonstrated that HEATR1, ZNF185, and SMAD4 expression are significantly associated with the prognosis with pancreatic cancer in the patients treated with gemcitabine chemotherapy. Here, ZNF185 is linked to pancreatic neoplasm.